Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use XELSTRYM safely and effectively. See full prescribing information for XELSTRYM. XELSTRYM® (dextroamphetamine) transdermal system, CII Initial U.S. Approval: 1975
Medication labelWhy this: Advisory · dailymed-prescription
XELSTRYM® is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older [see CLINICAL STUDIES (14)]. Limitations of Use The use of XELSTRYM is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage [see Warnings and Precautions (5.5), Use in Specific Populations (8.4)].
- generic_name
- dextroamphetamine
- product_names
- DEXTROAMPHETAMINE
- ndc
- 68968-0205, 68968-0210, 68968-0215, 68968-0220, 68968-0205-1, 68968-0205-3, 68968-0210-1, 68968-0210-3, 68968-0215-1, 68968-0215-3, 68968-0220-1, 68968-0220-3
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en